This is an optimized Investor Page for viewing on mobile devices, to view our entire Investor Relations site click here.
Jan 24, 2012
Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:
> Read More
Jan 17, 2012
Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2011 Financial Results
> Read More
Jan 3, 2012
Johnson & Johnson Announces First-Quarter 2012 Quarterly Dividend
> Read More
Dec 29, 2011
Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome
> Read More
Dec 8, 2011
Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
> Read More
© 1992-2008 JNJ Systems, Inc. All rights reserved.